<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00280904</url>
  </required_header>
  <id_info>
    <org_study_id>CRI-IN04-001</org_study_id>
    <nct_id>NCT00280904</nct_id>
  </id_info>
  <brief_title>A Registry for Comparing Catheter-Related Infection Rates Among Various Shunt Systems in the Treatment of Hydrocephalus</brief_title>
  <official_title>A Registry for Comparing Catheter-Related Infection Rates Among Various Shunt Systems in the Treatment of Hydrocephalus</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Codman &amp; Shurtleff</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Codman &amp; Shurtleff</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this Registry is to compare shunt/catheter-related infection rates among
      various shunt systems when used according to hospital standard of care to treat
      hydrocephalus.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Clinical trials show that the majority of infections in shunt systems originate from
      bacterial contamination introduced at the time of surgery and most appear by 3-4 weeks
      post-operatively. Protection must persist well beyond the surgical procedure to make certain
      that all contaminating bacteria are completely eradicated.

      Depending upon the institution, shunt infection rates have been known to be as little as 1%
      to as much as 25%. However, two prospective trials that have been published from large
      databases, with a consistent definition of infection, have indicated an overall infection
      rate of approximately 10%

      This prospective non-randomized, open-label Registry is designed to investigate and identify
      short-term shunt/catheter-related infection rates in ventriculoperitoneal shunt systems using
      various catheters during hospital standard of care treatment of Subjects with hydrocephalus.
      Prospective Subjects will include those receiving shunts for the first time (de novo) and
      those with previously implanted shunts for whom catheter or total system replacements are
      required.

      This Registry will enroll 450 implanted Subjects of any age who meet all the inclusion
      criteria and none of the exclusion criteria and who provide signed Informed Consent to
      participate in this clinical Registry

      Subjects will be followed for up to 90 days.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2006</start_date>
  <completion_date type="Actual">April 2008</completion_date>
  <primary_completion_date type="Actual">April 2008</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Subjects With Shunt Infections</measure>
    <time_frame>Implantation to Explant</time_frame>
    <description>Number of shunt infections occurring in subjects implanted with antibiotic impregnated catheters and standard catheters.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Non-infectious Antibiotic Impregnated (AI) and Standard Catheter Subjects With Shunt Failures</measure>
    <time_frame>April 2008</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">433</enrollment>
  <condition>Hydrocephalus</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Shunt catheter</intervention_name>
    <description>standard of care implantation of shunt (any brand). Subjects are followed for 90 days to obtain information about whether or not an infection occurred.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects of any age, gender and ethnicity, with hydrocephalus
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The Subject requires a surgical procedure to implant (de novo) a ventriculoperitoneal
             shunt or to replace an already implanted shunt catheter for the treatment of
             hydrocephalus.

          -  The Subject (family member/legal representative) has completed the Informed Consent
             process prior to enrollment into this Registry.

          -  The Subject (family member/legal representative) is willing to comply with the
             Registry protocol timelines &amp; requirements.

        Exclusion Criteria:

          -  The Subject's planned shunt has distal drainage to the heart.

          -  The Subject has an active infection of the indwelling shunt system, cerebrospinal
             fluid or abdominal cavity.

          -  The Subject has ventriculitis, peritonitis or meningitis.

          -  The Subject has sepsis.

          -  The Subject has a history of poor wound healing.

          -  The Subject has symptoms pertaining to: a skin infection at or near the site of any
             incisions; an ear infection on either side; a respiratory tract infection; or a
             urinary tract infection that, in the Investigator's opinion is clinically significant
             and might compromise the outcome of this Registry.

          -  The Subject has had any form of bowel surgery 30 days prior to device implant or
             anticipates bowel surgery within 90 days following device implant

          -  The Subject has loculation(s) within the ventricular system.

          -  The Subject is otherwise determined by the Investigator to be medically unsuitable for
             participation in this Registry.

          -  The Subject is currently enrolled in another drug or device trial or has been
             previously entered in this trial.

          -  The Subject exhibits other difficulties, which would preclude follow-up for 90 days.

          -  The Subject is a prisoner.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paul Steinbok, MBBS, FRCSC</last_name>
    <role>Study Chair</role>
    <affiliation>University of British Columbia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Children's memorial Hospital</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60614</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Penn State Milton S. Hershey Medical Center</name>
      <address>
        <city>Hershey</city>
        <state>Pennsylvania</state>
        <zip>17033</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>British Columbia Children's Hospital</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V6H 3V4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Prince of Wales Hospital</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ua Shan Hospital</name>
      <address>
        <city>Shanghai</city>
        <zip>200040</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Queen Mary Hospital</name>
      <address>
        <city>Hong Kong</city>
        <country>Hong Kong</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>All India Insitute of Medical Sciences</name>
      <address>
        <city>New Delhi</city>
        <zip>110029</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Neuroscience Institute</name>
      <address>
        <city>Singapore</city>
        <zip>308433</zip>
        <country>Singapore</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>China</country>
    <country>Hong Kong</country>
    <country>India</country>
    <country>Singapore</country>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Steinbok P, Milner R, Agrawal D, Farace E, Leung GK, Ng I, Tomita T, Wang E, Wang N, Wong GK, Zhou LF. A multicenter multinational registry for assessing ventriculoperitoneal shunt infections for hydrocephalus. Neurosurgery. 2010 Nov;67(5):1303-10. doi: 10.1227/NEU.0b013e3181f07e76.</citation>
    <PMID>20871445</PMID>
  </results_reference>
  <verification_date>February 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 20, 2006</study_first_submitted>
  <study_first_submitted_qc>January 20, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 24, 2006</study_first_posted>
  <results_first_submitted>November 17, 2010</results_first_submitted>
  <results_first_submitted_qc>February 5, 2013</results_first_submitted_qc>
  <results_first_posted type="Estimate">March 8, 2013</results_first_posted>
  <last_update_submitted>February 5, 2013</last_update_submitted>
  <last_update_submitted_qc>February 5, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 8, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Hydrocephalus</keyword>
  <keyword>Shunt</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hydrocephalus</mesh_term>
    <mesh_term>Catheter-Related Infections</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Ventriculoperitoneal Shunt Patients</title>
          <description>Patients receiving a de novo standard or antibiotic (AI) catheter implant or catheter replacement of a prior ventriculoperitoneal shunt.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="433"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="433"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Ventriculoperitoneal Shunt Patients</title>
          <description>Patients receiving a de novo standard or antibiotic (AI) catheter implant or catheter replacement of a prior ventriculoperitoneal shunt.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="433"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="183"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="193"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="31.3" spread="25.49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="194"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="239"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Secondary</type>
        <title>Non-infectious Antibiotic Impregnated (AI) and Standard Catheter Subjects With Shunt Failures</title>
        <time_frame>April 2008</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ventriculoperitoneal Shunt Patients</title>
            <description>Patients receiving a de novo antibiotic impregnated(AI)or standard catheter implant or catheter replacement of a prior ventriculoperitoneal shunt.</description>
          </group>
        </group_list>
        <measure>
          <title>Non-infectious Antibiotic Impregnated (AI) and Standard Catheter Subjects With Shunt Failures</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="433"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Subjects With Shunt Infections</title>
        <description>Number of shunt infections occurring in subjects implanted with antibiotic impregnated catheters and standard catheters.</description>
        <time_frame>Implantation to Explant</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ventriculoperitoneal Shunt Patients</title>
            <description>Patients receiving a de novo antibiotic impregnated (AI) or standard catheter implant or catheter replacement of a prior ventriculoperitoneal shunt.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Subjects With Shunt Infections</title>
          <description>Number of shunt infections occurring in subjects implanted with antibiotic impregnated catheters and standard catheters.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="433"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Ventriculoperitoneal Shunt Patients</title>
          <description>Patients receiving a de novo standard or antibiotic (AI) catheter implant or catheter replacement of a prior ventriculoperitoneal shunt.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="433"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="433"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>J. Thomas Megerian</name_or_title>
      <organization>Codman &amp; Shurtleff</organization>
      <phone>1-508-828-8274</phone>
      <email>jmegeri1@its.jnj.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

